Drug industry concerned that US track and trace deadlines could mean Rx shortages
This article was originally published in SRA
Executive Summary
US drug shortages could be one of the unintended consequences if the Food and Drug Administration does not allow some enforcement discretion in the beginning of 2015 as the first set of drug tracing requirements - the handoff of transaction information - go into effect, stakeholders told the agency at a traceability seminar hosted by the Healthcare Distribution Management Association on 11 November.